Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EMERSON ELECTRIC COEMR · Entity 2942 | Director | February 03, 2026 | February 05, 2026 |
| Ecovyst Inc.ECVT · Entity 4897 | Director | January 17, 2022 | January 19, 2022 |
| TEXAS INSTRUMENTS INCTXN · Entity 2834 | Director | May 28, 2026 | May 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EMERSON ELECTRIC CO
Report date February 03, 2026 · Filed February 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,867 |
Reported balance
After 2026-02-03 transaction · row 1
1 source rowRow 1 · 2026-02-03 · Grant · Acquired 1,251 · Balance 14,867 F1: Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2: Price is not applicable to acquisitions resulting from grants of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d).
F2: Price is not applicable to acquisitions resulting from grants of restricted stock units.
Ecovyst Inc.
Report date January 17, 2022 · Filed January 19, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 101,373 |
Reported balance
After 2022-01-17 transaction · row 1
1 source rowRow 1 · 2022-01-17 · Grant · Acquired 19,436 · Balance 101,373 |
TEXAS INSTRUMENTS INC
Report date May 28, 2026 · Filed May 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,359 |
Ending reported balance
After 2026-05-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-28 · Sale · Disposed 9,643 · Balance 14,716 F1: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $320.00 to $320.9867. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Row 2 · 2026-05-28 · Sale · Disposed 357 · Balance 14,359 |
Filing footnotes · ownership attribution and instrument terms
F1: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $320.00 to $320.9867. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Baker Hughes Co
Report date May 10, 2019 · Filed May 13, 2019
Section 16 reporting ended · disclosed 2019-05-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 514,950.5642 |
Reported balance
After 2019-05-10 transaction · row 1
1 source rowRow 1 · 2019-05-10 · Exercise / conversion · Acquired 4,893 · Balance 514,950.5642 |
| Restricted Stock Unit D 5_18SEC Table II · derivative / convertible security · Expires 2019-05-10 | Direct | 0 |
Reported balance
After 2019-05-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-05-10 · Exercise / conversion · Disposed 4,893 · Balance 0 F1: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer.
Baker Hughes Holdings LLC
Report date July 03, 2017 · Filed July 03, 2017
Section 16 reporting ended · disclosed 2017-07-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1.00 Par ValueSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2017-07-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-06-19 · Grant · Acquired 104.4452 · Balance 279,964.5127 F1: Acquisition under Employee Stock Purchase Plan exempt from Section 16b of the Securities Exchange Act of 1934 by Rule 16b-3. Row 2 · 2017-07-03 · Disposition to issuer · Disposed 279,964.5127 · Balance 0 F2: On the closing date (the "Closing Date") of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 30, 2016, among General Electric Company, a New York corporation, Baker Hughes Incorporated, a Delaware corporation ("BHI"), the Issuer and certain subsidiaries of BHI, as amended by that certain Amendment to Transaction Agreement and Plan of Merger dated as of March 27, 2017 (the "Transaction Agreement"), each outstanding share of common stock of the Issuer ("BHI Common Stock"), whether restricted or unrestricted, was cancelled and converted into the right to receive (a) one share of Class A common stock of Baker Hughes, a GE Company ("BHGE Common Stock") and (b) a special one-time cash dividend of $17.50 per share of BHGE Common Stock (the "Special Dividend"). |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $82.28 · Expires 2017-07-24 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-07-03 · Disposition to issuer · Disposed 9,801 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.92 · Expires 2018-01-23 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-07-03 · Disposition to issuer · Disposed 10,674 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.20 · Expires 2018-08-11 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-07-03 · Disposition to issuer · Disposed 9,716 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.18 · Expires 2019-01-21 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-07-03 · Disposition to issuer · Disposed 3,427 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.28 · Expires 2020-01-19 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-07-03 · Disposition to issuer · Disposed 2,115 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.17 · Expires 2020-07-21 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-07-03 · Disposition to issuer · Disposed 27,500 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $62.32 · Expires 2021-01-26 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-07-03 · Disposition to issuer · Disposed 27,600 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.00 · Expires 2021-07-19 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2017-07-03 · Disposition to issuer · Disposed 22,300 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.44 · Expires 2022-01-25 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2017-07-03 · Disposition to issuer · Disposed 73,696 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.30 · Expires 2022-07-16 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2017-07-03 · Disposition to issuer · Disposed 88,980 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.21 · Expires 2023-01-24 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2017-07-03 · Disposition to issuer · Disposed 94,033 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.75 · Expires 2023-07-24 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2017-07-03 · Disposition to issuer · Disposed 89,066 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.73 · Expires 2024-01-22 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2017-07-03 · Disposition to issuer · Disposed 88,723 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $72.70 · Expires 2024-07-14 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2017-07-03 · Disposition to issuer · Disposed 69,267 · Balance 0 F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2017-07-03 · Disposition to issuer · Disposed 55,711 · Balance 0 F4: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2017-07-03 · Disposition to issuer · Disposed 159,620 · Balance 0 F4: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2017-07-03 · Disposition to issuer · Disposed 83,974 · Balance 0 F4: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). |
Filing footnotes · ownership attribution and instrument terms
F1: Acquisition under Employee Stock Purchase Plan exempt from Section 16b of the Securities Exchange Act of 1934 by Rule 16b-3.
F2: On the closing date (the "Closing Date") of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 30, 2016, among General Electric Company, a New York corporation, Baker Hughes Incorporated, a Delaware corporation ("BHI"), the Issuer and certain subsidiaries of BHI, as amended by that certain Amendment to Transaction Agreement and Plan of Merger dated as of March 27, 2017 (the "Transaction Agreement"), each outstanding share of common stock of the Issuer ("BHI Common Stock"), whether restricted or unrestricted, was cancelled and converted into the right to receive (a) one share of Class A common stock of Baker Hughes, a GE Company ("BHGE Common Stock") and (b) a special one-time cash dividend of $17.50 per share of BHGE Common Stock (the "Special Dividend").
F3: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date.
F4: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2026 Filed May 30, 2026 00:58 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 357 | $321.01 | $114,599.46 |
DisclosureSEC source: 0001319699-26-000004 · wk-form4_1780102702.xml · nonDerivative · entry 2 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,359 Read SEC document |
| May 28, 2026 Filed May 30, 2026 00:58 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 9,643 | $320.41 | $3,089,689.52 |
DisclosureSEC source: 0001319699-26-000004 · wk-form4_1780102702.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,716 F1 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $320.00 to $320.9867. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 21:36 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,251 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001319699-26-000002 · wk-form4_1770327370.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,867 F1 · kind: Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock units. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:23 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 1,860 | $0.00 Strike: $218.97 | $0.00 |
DisclosureSEC source: 0000097476-26-000040 · wk-form4_1770067422.xml · derivative · entry 2 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,860 Underlying: Common Stock · 1,860 shares Expires 2036-01-29 F2 · derivative.exercise_date: The stock option becomes exercisable in four equal installments beginning on January 29, 2027. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:23 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0000097476-26-000040 · wk-form4_1770067422.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,359 F1 · shares: Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:13 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,476 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000032604-25-000018 · wk-form4_1738876380.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,616 F1 · kind: Grant to Reporting Person of 1,476 restricted stock units having a fair market value of $128.6800 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,476 restricted stock units having a fair market value of $128.6800 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock units. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 21:45 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 2,551 | $0.00 Strike: $187.03 | $0.00 |
DisclosureSEC source: 0001127602-25-002271 · form4.xml · derivative · entry 2 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,551 Underlying: Common Stock · 2,551 shares Expires 2035-01-27 F2 · derivative.exercise_date: The stock option becomes exercisable in four equal installments beginning on January 27, 2026. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 21:45 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 614 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-002271 · form4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,834 F1 · shares: Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:24 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,867 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-002549 · form4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,140 F1 · kind: Grant to Reporting Person of 1,867 restricted stock units having a fair market value of $93.7050 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,867 restricted stock units having a fair market value of $93.7050 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock units. Read SEC document |
| January 25, 2024 Filed Jan 29, 2024 21:39 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 3,066 | $0.00 Strike: $167.42 | $0.00 |
DisclosureSEC source: 0001127602-24-002440 · form4.xml · derivative · entry 2 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,066 Underlying: Common Stock · 3,066 shares Expires 2034-01-25 F2 · derivative.exercise_date: The stock option becomes exercisable in four equal annual installments beginning on January 25, 2025. Read SEC document |
| January 25, 2024 Filed Jan 29, 2024 21:39 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 686 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-002440 · form4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,220 F1 · shares: Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 21:36 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,933 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950138-23-000029 · edgar.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,273 F1 · kind: Grant to Reporting Person of 1,933 restricted stock units having a fair market value of $90.5250 per unit on the date of grant under shareholder approved benefit plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,933 restricted stock units having a fair market value of $90.5250 per unit on the date of grant under shareholder approved benefit plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock units. Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 21:57 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 2,159 | $0.00 Strike: $174.10 | $0.00 |
DisclosureSEC source: 0001127602-23-002681 · form4.xml · derivative · entry 2 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,159 Underlying: Common Stock · 2,159 shares Expires 2033-01-26 F2 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 26, 2024. Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 21:57 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 574 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-002681 · form4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,534 F1 · shares: Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 20:31 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,905 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950138-22-000042 · edgar.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,340 F1 · kind: Grant to Reporting Person of 1,905 shares of restricted stock having a fair market value of $91.83 per share on the date of grant under shareholder approved benefit plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,905 shares of restricted stock having a fair market value of $91.83 per share on the date of grant under shareholder approved benefit plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 22:34 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 2,512 | $0.00 Strike: $174.81 | $0.00 |
DisclosureSEC source: 0001127602-22-002573 · form4.xml · derivative · entry 2 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,512 Underlying: Common Stock · 2,512 shares Expires 2032-01-27 F2 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 27, 2023. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 22:34 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 572 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-002573 · form4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,960 F1 · shares: Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan. Read SEC document |
| January 17, 2022 Filed Jan 19, 2022 21:18 UTC | Ecovyst Inc. ECVT · Entity 4897 | GrantCommon Stock | 19,436 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-002399 · doc4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,373 Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 21:33 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,787 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950138-21-000097 · edgar.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,435 F1 · kind: Grant to Reporting Person of 1,787 shares of restricted stock having a fair market value of $83.905 per share on the date of grant under shareholder approved benefit plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,787 shares of restricted stock having a fair market value of $83.905 per share on the date of grant under shareholder approved benefit plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock. Read SEC document |
| January 28, 2021 Filed Feb 1, 2021 23:44 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 2,457 | $169.23 Strike: $169.23 | $415,798.11 |
DisclosureSEC source: 0001127602-21-003344 · form4.xml · derivative · entry 3 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,457 Underlying: Common Stock · 2,457 shares Expires 2031-01-28 F3 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 28, 2022. Read SEC document |
| January 28, 2021 Filed Feb 1, 2021 23:44 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | PurchaseCommon Stock | 5,975 | $166.91 | $997,294.42 |
DisclosureSEC source: 0001127602-21-003344 · form4.xml · nonDerivative · entry 2 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,388 F2 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $166.78 to $167.00. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| January 28, 2021 Filed Feb 1, 2021 23:44 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-003344 · form4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,413 F1 · shares: Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan. Read SEC document |
| January 18, 2021 Filed Jan 21, 2021 01:49 UTC | Ecovyst Inc. PQG · Entity 4897 | GrantCommon Stock | 12,995 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-002596 · doc4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,937 Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:34 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 2,030 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950138-20-000072 · edgar.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,648 F1 · kind: Grant to Reporting Person of 2,030 shares of restricted stock having a fair market value of $73.865 per share on the date of grant under shareholder approved benefit plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 2,030 shares of restricted stock having a fair market value of $73.865 per share on the date of grant under shareholder approved benefit plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 21:19 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 3,911 | $130.52 Strike: $130.52 | $510,463.72 |
DisclosureSEC source: 0001127602-20-002496 · form4.xml · derivative · entry 2 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,911 Underlying: Common Stock · 3,911 shares Expires 2030-01-24 F2 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 24, 2021. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 21:19 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 766 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-002496 · form4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,823 F1 · shares: Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan. Read SEC document |
| January 20, 2020 Filed Jan 23, 2020 01:54 UTC | Ecovyst Inc. PQG · Entity 4897 | GrantCommon Stock | 12,008 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-001741 · doc4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,942 Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 15:27 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,618 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950138-19-000341 · edgar.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,618 F1 · kind: Grant to Reporting Person of 1,618 shares of restricted stock having a fair market value of $61.79 per share on the date of grant under shareholder approved benefit plan pursuant to Rule 16b-3(d) in connection with annual retainer paid to all non-management directors. F1 · shares: Grant to Reporting Person of 1,618 shares of restricted stock having a fair market value of $61.79 per share on the date of grant under shareholder approved benefit plan pursuant to Rule 16b-3(d) in connection with annual retainer paid to all non-management directors. F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock. Read SEC document |
| May 10, 2019 Filed May 13, 2019 18:56 UTC | Baker Hughes Co BHGE · Entity 2993 | Exercise / conversionRestricted Stock Unit D 5_18 · Derivative | 4,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001701605-19-000046 · wf-form4_155777375631819.xml · derivative · entry 2 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,893 shares Expires 2019-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. Read SEC document |
| May 10, 2019 Filed May 13, 2019 18:56 UTC | Baker Hughes Co BHGE · Entity 2993 | Exercise / conversionClass A Common Stock | 4,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001701605-19-000046 · wf-form4_155777375631819.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,950.5642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 21:19 UTC | Ecovyst Inc. PQG · Entity 4897 | GrantCommon Stock | 12,979 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-007566 · doc4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,934 Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 23:44 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 4,532 | $104.41 Strike: $104.41 | $473,186.12 |
DisclosureSEC source: 0001127602-19-002958 · form4.xml · derivative · entry 2 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,532 Underlying: Common Stock · 4,532 shares Expires 2029-01-25 F2 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 25, 2020. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 23:44 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 957 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-002958 · form4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,057 F1 · shares: Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 17:41 UTC | Baker Hughes Co BHGE · Entity 2993 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,427 | $0.00 Strike: $11.68 | $0.00 |
DisclosureSEC source: 0001701605-18-000109 · wf-form4_154221727066482.xml · derivative · entry 2 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,427 shares Expires 2019-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 17:41 UTC | Baker Hughes Co BHGE · Entity 2993 | Exercise / conversionClass A Common Stock | 3,427 | $11.68 | $40,027.36 |
DisclosureSEC source: 0001701605-18-000109 · wf-form4_154221727066482.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,057.5642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person elected to exercise and hold the 3,427 shares, a permitted transaction under BHGE's Insider Trading Policy. Read SEC document |
| October 25, 2018 Filed Oct 29, 2018 20:44 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | PurchaseCommon Stock | 10,900 | $91.70 | $999,496.21 |
DisclosureSEC source: 0001127602-18-031208 · form4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,100 F1 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $91.68 to $91.78. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| July 01, 2018 Filed Jul 3, 2018 22:23 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-022729 · form4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 F1 · shares: Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan. Read SEC document |
| May 15, 2018 Filed May 17, 2018 21:51 UTC | Ecovyst Inc. PQG · Entity 4897 | PurchaseCommon Stock | 14,440 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-013270 · doc4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,955 F1 · kind: Represents a grant of restricted stock units. F1 · shares: Represents a grant of restricted stock units. F1 · price: Represents a grant of restricted stock units. Read SEC document |
| May 11, 2018 Filed May 14, 2018 21:03 UTC | Baker Hughes Co BHGE · Entity 2993 | GrantRestricted Stock Unit D 5_18 · Derivative | 4,893 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001701605-18-000069 · wf-form4_152633176559954.xml · derivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,893 Underlying: Class A Common Stock · 4,893 shares Expires 2019-05-11 F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F1 · price: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F2 · derivative.exercise_date: The restricted stock units vest on the first anniversary of the grant date. F2 · derivative.expiration_date: The restricted stock units vest on the first anniversary of the grant date. Read SEC document |
| May 09, 2018 Filed May 10, 2018 21:45 UTC | Baker Hughes Co BHGE · Entity 2993 | Exercise / conversionRestricted Stock Unit · Derivative | 4,176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001701605-18-000060 · wf-form4_152598871333702.xml · derivative · entry 2 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,176 shares Expires 2018-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F1 · price: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. Read SEC document |
| May 09, 2018 Filed May 10, 2018 21:45 UTC | Baker Hughes Co BHGE · Entity 2993 | Exercise / conversionClass A Common Stock | 4,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001701605-18-000060 · wf-form4_152598871333702.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,630.5642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 20:21 UTC | Ecovyst Inc. PQG · Entity 4897 | PurchaseCommon Stock | 17,140 | $14.54 | $249,184.75 |
DisclosureSEC source: 0000899243-18-008608 · doc4.xml · nonDerivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,515 Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 01:30 UTC | Baker Hughes Co BHGE · Entity 2993 | GrantRestricted Stock Unit · Derivative | 4,176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001701605-17-000081 · wf-form4_150181019797574.xml · derivative · entry 1 Craighead Martin S · CIK 0001319699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,176 Underlying: Class A Common Stock · 4,176 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer and will fully vest on May 9, 2018. F1 · price: The restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer and will fully vest on May 9, 2018. F1 · derivative.exercise_date: The restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer and will fully vest on May 9, 2018. F1 · derivative.expiration_date: The restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer and will fully vest on May 9, 2018. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:31 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerRestricted Stock Units · Derivative | 83,974 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-022530 · form4.xml · derivative · entry 19 Craighead Martin S · CIK 0001319699 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 83,974 shares Expires not disclosed F4 · derivative.exercise_price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F4 · price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F4 · derivative.exercise_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F4 · derivative.expiration_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:31 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerRestricted Stock Units · Derivative | 159,620 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-022530 · form4.xml · derivative · entry 18 Craighead Martin S · CIK 0001319699 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 159,620 shares Expires not disclosed F4 · derivative.exercise_price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F4 · price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F4 · derivative.exercise_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F4 · derivative.expiration_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:31 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerRestricted Stock Units · Derivative | 55,711 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-022530 · form4.xml · derivative · entry 17 Craighead Martin S · CIK 0001319699 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 55,711 shares Expires not disclosed F4 · derivative.exercise_price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F4 · price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F4 · derivative.exercise_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F4 · derivative.expiration_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:31 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 69,267 | Not disclosed Strike: $72.70 | Not disclosed |
DisclosureSEC source: 0001127602-17-022530 · form4.xml · derivative · entry 16 Craighead Martin S · CIK 0001319699 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 69,267 shares Expires 2024-07-14 F3 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F3 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:31 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 88,723 | Not disclosed Strike: $56.73 | Not disclosed |
DisclosureSEC source: 0001127602-17-022530 · form4.xml · derivative · entry 15 Craighead Martin S · CIK 0001319699 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 88,723 shares Expires 2024-01-22 F3 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F3 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:31 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 89,066 | Not disclosed Strike: $47.75 | Not disclosed |
DisclosureSEC source: 0001127602-17-022530 · form4.xml · derivative · entry 14 Craighead Martin S · CIK 0001319699 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 89,066 shares Expires 2023-07-24 F3 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F3 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:31 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 94,033 | Not disclosed Strike: $45.21 | Not disclosed |
DisclosureSEC source: 0001127602-17-022530 · form4.xml · derivative · entry 13 Craighead Martin S · CIK 0001319699 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 94,033 shares Expires 2023-01-24 F3 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F3 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.